Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for DCGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -1.663M
March 31, 2026 -2.465M
December 31, 2025 -1.865M
September 30, 2025 -33.05M
June 30, 2025 -7.382M
March 31, 2025 -8.518M
December 31, 2024 -7.856M
September 30, 2024 -5.503M
June 30, 2024 -8.067M
March 31, 2024 -0.8816M
December 31, 2023 12.98M
September 30, 2023 -8.667M
Date Value
June 30, 2023 8.760M
March 31, 2023 -11.95M
December 31, 2022 -6.866M
September 30, 2022 -0.4364M
June 30, 2022 -1.374M
March 31, 2022 0.4338M
December 31, 2021
September 30, 2021 -0.9775M
June 30, 2021 7.599M
March 31, 2021 -0.8836M
December 31, 2020 116.12M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Dogecoin Cash, Inc. 0.0001M
Cryo-Cell International, Inc. -1.623M
Privia Health Group, Inc. 0.826M
Strata Critical Medical, Inc. -4.203M
Syra Health Corp. -0.0798M